Literature DB >> 27532149

Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.

Marcela S Cavalcanti1, Anne M Schultheis, Caleb Ho, Lu Wang, Deborah F DeLair, Britta Weigelt, Ginger Gardner, Stuart M Lichtman, Meera Hameed, Kay J Park.   

Abstract

Human papillomavirus (HPV)-negative cervical carcinomas are uncommon and typically encompass unusual histologic subtypes. Mesonephric adenocarcinoma is one such subtype. Mesonephric tumors in the female genital tract are thought to arise from Wolffian remnants, and are extremely rare tumors with widely variable morphology. Sarcomatoid dedifferentiation has been previously described in a few cases, but other forms of dedifferentiation have not been reported. Neuroendocrine carcinoma of the cervix (e.g. small cell carcinoma) is associated with HPV infection, typically HPV 18. These tumors often arise in association with a conventional epithelial component such as squamous cell carcinoma or usual-type endocervical adenocarcinoma. We describe a case of mesonephric adenocarcinoma of the uterine cervix associated with an HPV-negative high-grade neuroendocrine carcinoma at the morphologic and immunophenotypic level, for which we performed targeted massively parallel sequencing analysis of the 2 elements. Both components shared identical mutations in U2AF1 p.R156H (c.467G>A) and GATA3 p.M422fs (c.1263dupG), as well as MYCN amplification. In addition, the neuroendocrine carcinoma harbored TP53 and MST1R mutations not present in the mesonephric carcinoma. Our data suggest a clonal origin of the 2 components of this rare entity, rather than a collision tumor.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27532149      PMCID: PMC5500437          DOI: 10.1097/PGP.0000000000000306

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  46 in total

1.  p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.

Authors:  Lars-Christian Horn; Kristin Lindner; Grit Szepankiewicz; Jeanett Edelmann; Bettina Hentschel; Andrea Tannapfel; Karl Bilek; Uwe-Gerd Liebert; Cristine E Richter; Jens Einenkel; Cornelia Leo
Journal:  Int J Gynecol Pathol       Date:  2006-04       Impact factor: 2.762

2.  Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.

Authors:  Andres A Roma; Abha Goyal; Bin Yang
Journal:  Int J Gynecol Pathol       Date:  2015-09       Impact factor: 2.762

3.  Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.

Authors:  Abha Goyal; Bin Yang
Journal:  Int J Gynecol Pathol       Date:  2014-11       Impact factor: 2.762

4.  Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.

Authors:  J A Ferry; R E Scully
Journal:  Am J Surg Pathol       Date:  1990-12       Impact factor: 6.394

5.  GATA Transcription Factors and Cancer.

Authors:  Rena Zheng; Gerd A Blobel
Journal:  Genes Cancer       Date:  2010-12

6.  Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases.

Authors:  Silvia Bagué; Ingrid M Rodríguez; Jaime Prat
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

7.  Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authors:  Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

8.  The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.

Authors:  Bryan King; Thomas Trimarchi; Linsey Reavie; Luyao Xu; Jasper Mullenders; Panagiotis Ntziachristos; Beatriz Aranda-Orgilles; Arianne Perez-Garcia; Junwei Shi; Christopher Vakoc; Peter Sandy; Steven S Shen; Adolfo Ferrando; Iannis Aifantis
Journal:  Cell       Date:  2013-06-20       Impact factor: 41.582

Review 9.  Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature.

Authors:  Shiori Meguro; Masanori Yasuda; Michio Shimizu; Akira Kurosaki; Keiichi Fujiwara
Journal:  Diagn Pathol       Date:  2013-05-07       Impact factor: 2.644

Review 10.  The many faces of neuroendocrine differentiation in prostate cancer progression.

Authors:  Stéphane Terry; Himisha Beltran
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

View more
  8 in total

1.  Mesonephric adenocarcinoma of the uterine cervix with rare lung metastases: A case report and review of the literature.

Authors:  Li-Li Jiang; De-Ming Tong; Zi-Yi Feng; Kui-Ran Liu
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

2.  Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.

Authors:  Cathleen E Matrai; Kentaro Ohara; Kenneth Wha Eng; Shannon M Glynn; Pooja Chandra; Sudeshna Chatterjee-Paer; Samaneh Motanagh; Susanna Mirabelli; Boaz Kurtis; Bing He; Alexandros Sigaras; Divya Gupta; Eloise Chapman-Davis; Kevin Holcomb; Andrea Sboner; Olivier Elemento; Lora Hedrick Ellenson; Juan Miguel Mosquera
Journal:  Int J Gynecol Pathol       Date:  2021-09-06       Impact factor: 3.326

3.  Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases.

Authors:  Edaise M da Silva; Daniel J Fix; Ana Paula Martins Sebastiao; Pier Selenica; Lorenzo Ferrando; Sarah H Kim; Anthe Stylianou; Arnaud Da Cruz Paula; Fresia Pareja; Evan S Smith; Ahmet Zehir; Jason A Konner; Karen Cadoo; Jorge S Reis-Filho; Nadeem R Abu-Rustum; Jennifer J Mueller; Britta Weigelt; Kay J Park
Journal:  Mod Pathol       Date:  2021-03-26       Impact factor: 7.842

4.  A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial Cancers.

Authors:  Bryan A Smith; Nikolas G Balanis; Avinash Nanjundiah; Katherine M Sheu; Brandon L Tsai; Qingfu Zhang; Jung Wook Park; Michael Thompson; Jiaoti Huang; Owen N Witte; Thomas G Graeber
Journal:  Cell Rep       Date:  2018-09-18       Impact factor: 9.995

5.  Neuroendocrine carcinoma of the cervix: a systematic review of the literature.

Authors:  Clemens B Tempfer; Iris Tischoff; Askin Dogan; Ziad Hilal; Beate Schultheis; Peter Kern; Günther A Rezniczek
Journal:  BMC Cancer       Date:  2018-05-04       Impact factor: 4.430

6.  Clinical profile and treatment outcome of collision carcinoma in cervix.

Authors:  Pei Shu; Rui Li; Dan Xie; Ying He; Xin Wang; Qingli Li
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

7.  Mesonephric Adenocarcinoma of the Vagina Harboring TP53 Mutation.

Authors:  Hyunjee Lee; Hyunjin Kim; Hyun-Soo Kim
Journal:  Diagnostics (Basel)       Date:  2022-01-05

Review 8.  Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers.

Authors:  Hiroshi Yoshida; Kouya Shiraishi; Tomoyasu Kato
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.